Second medical opinion in oncological setting

•The second opinion is increasingly requested by both doctors and cancer patients.•It involves severe diagnosis, choice of treatment or communication difficulties.•Few studies have addressed this issue with no general consensus.•Our decalogue can be a useful tool to deal with the second opinion requ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical reviews in oncology/hematology 2021-04, Vol.160, p.103282-103282, Article 103282
Hauptverfasser: Maruzzo, Marco, La Verde, Nicla, Russo, Antonio, Marchetti, Paolo, Scagnoli, Simone, Gonzato, Ornella, Di Maio, Massimo, Zagonel, Vittorina, Galvano, Antonio, Lanzetta, Gaetano, Perrone, Francesco, Beretta, Giordano, Bordonaro, Roberto, Comandone, Alessandro, Cinieri, Saverio, Nicolis, Fabrizio, Gori, Stefania
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 103282
container_issue
container_start_page 103282
container_title Critical reviews in oncology/hematology
container_volume 160
creator Maruzzo, Marco
La Verde, Nicla
Russo, Antonio
Marchetti, Paolo
Scagnoli, Simone
Gonzato, Ornella
Di Maio, Massimo
Zagonel, Vittorina
Galvano, Antonio
Lanzetta, Gaetano
Perrone, Francesco
Beretta, Giordano
Bordonaro, Roberto
Comandone, Alessandro
Cinieri, Saverio
Nicolis, Fabrizio
Gori, Stefania
description •The second opinion is increasingly requested by both doctors and cancer patients.•It involves severe diagnosis, choice of treatment or communication difficulties.•Few studies have addressed this issue with no general consensus.•Our decalogue can be a useful tool to deal with the second opinion request. Oncological patients increasingly require second medical opinions to feel more likely confident with their oncologists and treatments, although this could lead to wrong opinions and delay in the start of treatments. Second opinions can be required also by physicians to obtain advices, especially in case of rare tumors. The request of new opinions is documented in radiology and pathology settings too, with not negligible discrepancy rate. Conversely, the role in general medical/surgical conditions has not been well established. Literature is poor of studies relative to second opinions or they are more focused on patient's motivations. For these reasons, AIOM (Italian Association of Medical Oncology) and AIOM Foundation faced this topic during the 7th Annual Meeting on Ethics in Oncology (Ragusa, 4–5 t h May 2018). In this position paper we report reasons, limits, advantages and outcomes of second medical opinion and the respective Decalogue in the oncological setting.
doi_str_mv 10.1016/j.critrevonc.2021.103282
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2498518633</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1040842821000706</els_id><sourcerecordid>2498518633</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-9c9032ae90e05b6859c4a34f2156b7ae00275b42bd9222d9d93d030591d6542d3</originalsourceid><addsrcrecordid>eNqNkE1PGzEQhq0KVGjoX6j2WAltGH_u-kijfiAhcQDO1q49iRxt7GA7VPx7DEnhWE4ejZ53PPMQ0lCYU6DqYj23yZeEjzHYOQNGa5uznn0ip7TvdAtC0aNag4C2F6w_IV9yXgOAEKr7TE44V53UIE9Je4s2Btds0Hk7TE3c-uBjaHxo6uw4xdVrO2MpPqzOyPFymDJ-Pbwzcv_r593iT3t98_tqcXndWsFEabXVdZ0BNSDIUfVSWzFwsWRUqrEbEIB1chRsdJox5rTT3AEHqalTUjDHZ-T7fu42xYcd5mI2PlucpiFg3GXDhO4l7RXnFe33qE0x54RLs01-M6QnQ8G8yDJr8y7LvMgye1k1-u3wy26s978F_9l5n_0Xx7jM1mOw-IZVnUpUinW1ArrwZShV3SLuQqnR849HK_1jT2OV-ugxmUPC-YS2GBf9_895Bv0Qnss</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2498518633</pqid></control><display><type>article</type><title>Second medical opinion in oncological setting</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Maruzzo, Marco ; La Verde, Nicla ; Russo, Antonio ; Marchetti, Paolo ; Scagnoli, Simone ; Gonzato, Ornella ; Di Maio, Massimo ; Zagonel, Vittorina ; Galvano, Antonio ; Lanzetta, Gaetano ; Perrone, Francesco ; Beretta, Giordano ; Bordonaro, Roberto ; Comandone, Alessandro ; Cinieri, Saverio ; Nicolis, Fabrizio ; Gori, Stefania</creator><creatorcontrib>Maruzzo, Marco ; La Verde, Nicla ; Russo, Antonio ; Marchetti, Paolo ; Scagnoli, Simone ; Gonzato, Ornella ; Di Maio, Massimo ; Zagonel, Vittorina ; Galvano, Antonio ; Lanzetta, Gaetano ; Perrone, Francesco ; Beretta, Giordano ; Bordonaro, Roberto ; Comandone, Alessandro ; Cinieri, Saverio ; Nicolis, Fabrizio ; Gori, Stefania</creatorcontrib><description>•The second opinion is increasingly requested by both doctors and cancer patients.•It involves severe diagnosis, choice of treatment or communication difficulties.•Few studies have addressed this issue with no general consensus.•Our decalogue can be a useful tool to deal with the second opinion request. Oncological patients increasingly require second medical opinions to feel more likely confident with their oncologists and treatments, although this could lead to wrong opinions and delay in the start of treatments. Second opinions can be required also by physicians to obtain advices, especially in case of rare tumors. The request of new opinions is documented in radiology and pathology settings too, with not negligible discrepancy rate. Conversely, the role in general medical/surgical conditions has not been well established. Literature is poor of studies relative to second opinions or they are more focused on patient's motivations. For these reasons, AIOM (Italian Association of Medical Oncology) and AIOM Foundation faced this topic during the 7th Annual Meeting on Ethics in Oncology (Ragusa, 4–5 t h May 2018). In this position paper we report reasons, limits, advantages and outcomes of second medical opinion and the respective Decalogue in the oncological setting.</description><identifier>ISSN: 1040-8428</identifier><identifier>EISSN: 1879-0461</identifier><identifier>DOI: 10.1016/j.critrevonc.2021.103282</identifier><identifier>PMID: 33675905</identifier><language>eng</language><publisher>NEW YORK: Elsevier B.V</publisher><subject>AIOM ; Decalogue ; Ethics ; Hematology ; Humans ; Italy ; Life Sciences &amp; Biomedicine ; Medical Oncology ; Meeting ; Oncology ; Physicians ; Referral and Consultation ; Science &amp; Technology ; Second medical opinions</subject><ispartof>Critical reviews in oncology/hematology, 2021-04, Vol.160, p.103282-103282, Article 103282</ispartof><rights>2021 Elsevier B.V.</rights><rights>Copyright © 2021 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>2</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000640532700001</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c424t-9c9032ae90e05b6859c4a34f2156b7ae00275b42bd9222d9d93d030591d6542d3</citedby><cites>FETCH-LOGICAL-c424t-9c9032ae90e05b6859c4a34f2156b7ae00275b42bd9222d9d93d030591d6542d3</cites><orcidid>0000-0002-9064-8761 ; 0000-0003-4943-5622 ; 0000-0003-4365-5683 ; 0000-0002-9738-0526 ; 0000-0001-8906-3785 ; 0000-0002-6541-1228 ; 0000-0002-4370-2008 ; 0000-0002-8427-7765</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.critrevonc.2021.103282$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33675905$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maruzzo, Marco</creatorcontrib><creatorcontrib>La Verde, Nicla</creatorcontrib><creatorcontrib>Russo, Antonio</creatorcontrib><creatorcontrib>Marchetti, Paolo</creatorcontrib><creatorcontrib>Scagnoli, Simone</creatorcontrib><creatorcontrib>Gonzato, Ornella</creatorcontrib><creatorcontrib>Di Maio, Massimo</creatorcontrib><creatorcontrib>Zagonel, Vittorina</creatorcontrib><creatorcontrib>Galvano, Antonio</creatorcontrib><creatorcontrib>Lanzetta, Gaetano</creatorcontrib><creatorcontrib>Perrone, Francesco</creatorcontrib><creatorcontrib>Beretta, Giordano</creatorcontrib><creatorcontrib>Bordonaro, Roberto</creatorcontrib><creatorcontrib>Comandone, Alessandro</creatorcontrib><creatorcontrib>Cinieri, Saverio</creatorcontrib><creatorcontrib>Nicolis, Fabrizio</creatorcontrib><creatorcontrib>Gori, Stefania</creatorcontrib><title>Second medical opinion in oncological setting</title><title>Critical reviews in oncology/hematology</title><addtitle>CRIT REV ONCOL HEMAT</addtitle><addtitle>Crit Rev Oncol Hematol</addtitle><description>•The second opinion is increasingly requested by both doctors and cancer patients.•It involves severe diagnosis, choice of treatment or communication difficulties.•Few studies have addressed this issue with no general consensus.•Our decalogue can be a useful tool to deal with the second opinion request. Oncological patients increasingly require second medical opinions to feel more likely confident with their oncologists and treatments, although this could lead to wrong opinions and delay in the start of treatments. Second opinions can be required also by physicians to obtain advices, especially in case of rare tumors. The request of new opinions is documented in radiology and pathology settings too, with not negligible discrepancy rate. Conversely, the role in general medical/surgical conditions has not been well established. Literature is poor of studies relative to second opinions or they are more focused on patient's motivations. For these reasons, AIOM (Italian Association of Medical Oncology) and AIOM Foundation faced this topic during the 7th Annual Meeting on Ethics in Oncology (Ragusa, 4–5 t h May 2018). In this position paper we report reasons, limits, advantages and outcomes of second medical opinion and the respective Decalogue in the oncological setting.</description><subject>AIOM</subject><subject>Decalogue</subject><subject>Ethics</subject><subject>Hematology</subject><subject>Humans</subject><subject>Italy</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Medical Oncology</subject><subject>Meeting</subject><subject>Oncology</subject><subject>Physicians</subject><subject>Referral and Consultation</subject><subject>Science &amp; Technology</subject><subject>Second medical opinions</subject><issn>1040-8428</issn><issn>1879-0461</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>GIZIO</sourceid><sourceid>HGBXW</sourceid><sourceid>EIF</sourceid><recordid>eNqNkE1PGzEQhq0KVGjoX6j2WAltGH_u-kijfiAhcQDO1q49iRxt7GA7VPx7DEnhWE4ejZ53PPMQ0lCYU6DqYj23yZeEjzHYOQNGa5uznn0ip7TvdAtC0aNag4C2F6w_IV9yXgOAEKr7TE44V53UIE9Je4s2Btds0Hk7TE3c-uBjaHxo6uw4xdVrO2MpPqzOyPFymDJ-Pbwzcv_r593iT3t98_tqcXndWsFEabXVdZ0BNSDIUfVSWzFwsWRUqrEbEIB1chRsdJox5rTT3AEHqalTUjDHZ-T7fu42xYcd5mI2PlucpiFg3GXDhO4l7RXnFe33qE0x54RLs01-M6QnQ8G8yDJr8y7LvMgye1k1-u3wy26s978F_9l5n_0Xx7jM1mOw-IZVnUpUinW1ArrwZShV3SLuQqnR849HK_1jT2OV-ugxmUPC-YS2GBf9_895Bv0Qnss</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Maruzzo, Marco</creator><creator>La Verde, Nicla</creator><creator>Russo, Antonio</creator><creator>Marchetti, Paolo</creator><creator>Scagnoli, Simone</creator><creator>Gonzato, Ornella</creator><creator>Di Maio, Massimo</creator><creator>Zagonel, Vittorina</creator><creator>Galvano, Antonio</creator><creator>Lanzetta, Gaetano</creator><creator>Perrone, Francesco</creator><creator>Beretta, Giordano</creator><creator>Bordonaro, Roberto</creator><creator>Comandone, Alessandro</creator><creator>Cinieri, Saverio</creator><creator>Nicolis, Fabrizio</creator><creator>Gori, Stefania</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>17B</scope><scope>BLEPL</scope><scope>DTL</scope><scope>DVR</scope><scope>EGQ</scope><scope>GIZIO</scope><scope>HGBXW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-9064-8761</orcidid><orcidid>https://orcid.org/0000-0003-4943-5622</orcidid><orcidid>https://orcid.org/0000-0003-4365-5683</orcidid><orcidid>https://orcid.org/0000-0002-9738-0526</orcidid><orcidid>https://orcid.org/0000-0001-8906-3785</orcidid><orcidid>https://orcid.org/0000-0002-6541-1228</orcidid><orcidid>https://orcid.org/0000-0002-4370-2008</orcidid><orcidid>https://orcid.org/0000-0002-8427-7765</orcidid></search><sort><creationdate>202104</creationdate><title>Second medical opinion in oncological setting</title><author>Maruzzo, Marco ; La Verde, Nicla ; Russo, Antonio ; Marchetti, Paolo ; Scagnoli, Simone ; Gonzato, Ornella ; Di Maio, Massimo ; Zagonel, Vittorina ; Galvano, Antonio ; Lanzetta, Gaetano ; Perrone, Francesco ; Beretta, Giordano ; Bordonaro, Roberto ; Comandone, Alessandro ; Cinieri, Saverio ; Nicolis, Fabrizio ; Gori, Stefania</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-9c9032ae90e05b6859c4a34f2156b7ae00275b42bd9222d9d93d030591d6542d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>AIOM</topic><topic>Decalogue</topic><topic>Ethics</topic><topic>Hematology</topic><topic>Humans</topic><topic>Italy</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Medical Oncology</topic><topic>Meeting</topic><topic>Oncology</topic><topic>Physicians</topic><topic>Referral and Consultation</topic><topic>Science &amp; Technology</topic><topic>Second medical opinions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maruzzo, Marco</creatorcontrib><creatorcontrib>La Verde, Nicla</creatorcontrib><creatorcontrib>Russo, Antonio</creatorcontrib><creatorcontrib>Marchetti, Paolo</creatorcontrib><creatorcontrib>Scagnoli, Simone</creatorcontrib><creatorcontrib>Gonzato, Ornella</creatorcontrib><creatorcontrib>Di Maio, Massimo</creatorcontrib><creatorcontrib>Zagonel, Vittorina</creatorcontrib><creatorcontrib>Galvano, Antonio</creatorcontrib><creatorcontrib>Lanzetta, Gaetano</creatorcontrib><creatorcontrib>Perrone, Francesco</creatorcontrib><creatorcontrib>Beretta, Giordano</creatorcontrib><creatorcontrib>Bordonaro, Roberto</creatorcontrib><creatorcontrib>Comandone, Alessandro</creatorcontrib><creatorcontrib>Cinieri, Saverio</creatorcontrib><creatorcontrib>Nicolis, Fabrizio</creatorcontrib><creatorcontrib>Gori, Stefania</creatorcontrib><collection>Web of Knowledge</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Social Sciences Citation Index</collection><collection>Web of Science Primary (SCIE, SSCI &amp; AHCI)</collection><collection>Web of Science - Social Sciences Citation Index – 2021</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical reviews in oncology/hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maruzzo, Marco</au><au>La Verde, Nicla</au><au>Russo, Antonio</au><au>Marchetti, Paolo</au><au>Scagnoli, Simone</au><au>Gonzato, Ornella</au><au>Di Maio, Massimo</au><au>Zagonel, Vittorina</au><au>Galvano, Antonio</au><au>Lanzetta, Gaetano</au><au>Perrone, Francesco</au><au>Beretta, Giordano</au><au>Bordonaro, Roberto</au><au>Comandone, Alessandro</au><au>Cinieri, Saverio</au><au>Nicolis, Fabrizio</au><au>Gori, Stefania</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Second medical opinion in oncological setting</atitle><jtitle>Critical reviews in oncology/hematology</jtitle><stitle>CRIT REV ONCOL HEMAT</stitle><addtitle>Crit Rev Oncol Hematol</addtitle><date>2021-04</date><risdate>2021</risdate><volume>160</volume><spage>103282</spage><epage>103282</epage><pages>103282-103282</pages><artnum>103282</artnum><issn>1040-8428</issn><eissn>1879-0461</eissn><abstract>•The second opinion is increasingly requested by both doctors and cancer patients.•It involves severe diagnosis, choice of treatment or communication difficulties.•Few studies have addressed this issue with no general consensus.•Our decalogue can be a useful tool to deal with the second opinion request. Oncological patients increasingly require second medical opinions to feel more likely confident with their oncologists and treatments, although this could lead to wrong opinions and delay in the start of treatments. Second opinions can be required also by physicians to obtain advices, especially in case of rare tumors. The request of new opinions is documented in radiology and pathology settings too, with not negligible discrepancy rate. Conversely, the role in general medical/surgical conditions has not been well established. Literature is poor of studies relative to second opinions or they are more focused on patient's motivations. For these reasons, AIOM (Italian Association of Medical Oncology) and AIOM Foundation faced this topic during the 7th Annual Meeting on Ethics in Oncology (Ragusa, 4–5 t h May 2018). In this position paper we report reasons, limits, advantages and outcomes of second medical opinion and the respective Decalogue in the oncological setting.</abstract><cop>NEW YORK</cop><pub>Elsevier B.V</pub><pmid>33675905</pmid><doi>10.1016/j.critrevonc.2021.103282</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-9064-8761</orcidid><orcidid>https://orcid.org/0000-0003-4943-5622</orcidid><orcidid>https://orcid.org/0000-0003-4365-5683</orcidid><orcidid>https://orcid.org/0000-0002-9738-0526</orcidid><orcidid>https://orcid.org/0000-0001-8906-3785</orcidid><orcidid>https://orcid.org/0000-0002-6541-1228</orcidid><orcidid>https://orcid.org/0000-0002-4370-2008</orcidid><orcidid>https://orcid.org/0000-0002-8427-7765</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1040-8428
ispartof Critical reviews in oncology/hematology, 2021-04, Vol.160, p.103282-103282, Article 103282
issn 1040-8428
1879-0461
language eng
recordid cdi_proquest_miscellaneous_2498518633
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects AIOM
Decalogue
Ethics
Hematology
Humans
Italy
Life Sciences & Biomedicine
Medical Oncology
Meeting
Oncology
Physicians
Referral and Consultation
Science & Technology
Second medical opinions
title Second medical opinion in oncological setting
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A12%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Second%20medical%20opinion%20in%20oncological%20setting&rft.jtitle=Critical%20reviews%20in%20oncology/hematology&rft.au=Maruzzo,%20Marco&rft.date=2021-04&rft.volume=160&rft.spage=103282&rft.epage=103282&rft.pages=103282-103282&rft.artnum=103282&rft.issn=1040-8428&rft.eissn=1879-0461&rft_id=info:doi/10.1016/j.critrevonc.2021.103282&rft_dat=%3Cproquest_cross%3E2498518633%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2498518633&rft_id=info:pmid/33675905&rft_els_id=S1040842821000706&rfr_iscdi=true